Treatment of rheumatoid arthritis with PEGylated recombinant human soluble tumour necrosis factor receptor type I: a clinical update

被引：19

作者：

Davis, MW

Feige, U

Bendele, AM

Martin, SW

Edwards, CK

机构：

[1] Amgen Inc, Clin Dev, Thousand Oaks, CA 91320 USA

[2] Amgen Inc, Dept Pharmacol, Thousand Oaks, CA 91320 USA

[3] Univ Colorado, Bolder Path Inc, Boulder, CO 80309 USA

[4] Amgen Inc, Res & Dev, Thousand Oaks, CA 91320 USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2000年 / 59卷

关键词：

D O I：

10.1136/ard.59.suppl_1.i41

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：41 / 43

页数：3

共 16 条

[1]

Bendele AM, 1999, CLIN EXP RHEUMATOL, V17, P553

[2] Combination benefit of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) and dexamethasone or indomethacin in adjuvant arthritic rats [J].

Bendele, AM ;

McComb, J ;

Gould, T ;

Frazier, J ;

Chlipala, ES ;

Seely, J ;

Kieft, G ;

Wolf, J ;

Edwards, CK .

INFLAMMATION RESEARCH, 1999, 48 (08) :453-460

[3]

Bendele AM, 1999, ARTHRITIS RHEUM, V42, pS171

[4]

Caldwell JR, 1999, ARTHRITIS RHEUM, V42, pS236

[5]

Davis MW, 1999, ARTHRITIS RHEUM, V42, pS77

[6]

Edwards CK, 1999, ANN RHEUM DIS, V58, P73

[7]

Feige U, 1999, ARTHRITIS RHEUM, V42, pS383

[8] Different roles of tumour necrosis factor α and interleukin 1 in murine streptococcal cell wall arthritis [J].

Kuiper, S ;

Joosten, LAB ;

Bendele, AM ;

Edwards, CK ;

Arntz, OJ ;

Helsen, MMA ;

van de Loo, FAJ ;

van den Berg, WB .

CYTOKINE, 1998, 10 (09) :690-702

[9]

Martin SW, 1999, ARTHRITIS RHEUM, V42, pS79

[10]

McComb J, 1999, J RHEUMATOL, V26, P1347

← 1 2 →